FBInvestor
Stocks / Aslan Pharmaceuticals Lt Adr
Institutional Ownership

Aslan Pharmaceuticals Lt Adr

CUSIP 04522R309COMASLNEURQ1 2026

Dividends

Dividends-per-share are sourced from SEC XBRL filings. Either this issuer doesn't declare a common dividend, or it isn't ingested yet (we cover the top issuers first).

Coming soon